INOFEA's Series A - II Round

INOFEA raised a round of funding on December 04, 2017.

INOFEA owns a nanotechnology platform to shield sensitive enzymes and demonstrating benefits to customers in a number of biopharma-related applications.…

Articles about INOFEA's Series A - II Round: